UY26503A1 - "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL" - Google Patents

"DRUG DOSAGE FORM DRIVEN BY A HYDROGEL"

Info

Publication number
UY26503A1
UY26503A1 UY26503A UY26503A UY26503A1 UY 26503 A1 UY26503 A1 UY 26503A1 UY 26503 A UY26503 A UY 26503A UY 26503 A UY26503 A UY 26503A UY 26503 A1 UY26503 A1 UY 26503A1
Authority
UY
Uruguay
Prior art keywords
drug
core
dosage form
hydrogel
drug dosage
Prior art date
Application number
UY26503A
Other languages
Spanish (es)
Inventor
William John Curatolo
Avinash Govind Thombre
Leah Elizabeth Appel
Dwayne Thomas Friesen
Mark Brian Chidlaw
Ronald Arthur Beyerinck
Kellv Lincoln Smith
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to UY26503A priority Critical patent/UY26503A1/en
Publication of UY26503A1 publication Critical patent/UY26503A1/en

Links

Abstract

Una forma de dosificación de liberación controlada tiene un núcleo recubierto, comprendiendo el núcleo una composición que contiene a un fármaco y una composición hinchable en agua, ocupando cada una regiones separadas en el núcleo. La composición que contiene el fármaco comprende un fármaco de solubilidad baja y un agente que retiene el fármaco. El recubrimiento alrededor del núcleo es permeable al agua e insoluble en agua y tiene por lo menos un orificio de salida. Se describe diversas formulaciones que tienen perfiles específicos de liberación del fármaco.A controlled release dosage form has a coated core, the core comprising a composition containing a drug and a water swellable composition, each occupying separate regions in the core. The drug-containing composition comprises a low-solubility drug and a drug-retaining agent. The coating around the core is water permeable and insoluble in water and has at least one outlet hole. Various formulations are described that have specific drug release profiles.

UY26503A 2000-12-22 2000-12-22 "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL" UY26503A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26503A UY26503A1 (en) 2000-12-22 2000-12-22 "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26503A UY26503A1 (en) 2000-12-22 2000-12-22 "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL"

Publications (1)

Publication Number Publication Date
UY26503A1 true UY26503A1 (en) 2001-07-31

Family

ID=38812308

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26503A UY26503A1 (en) 2000-12-22 2000-12-22 "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL"

Country Status (1)

Country Link
UY (1) UY26503A1 (en)

Similar Documents

Publication Publication Date Title
AR027091A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
DOP2001000229A (en) HYDROGEL ACTIVATED DRUG DOSAGE FORM
DE60005819D1 (en) TASTE-MASKED ORAL PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED DELIVERY
GT199800136A (en) SOLID PHARMACEUTICAL DOSAGE FORMS.
ES2077530B1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS TO CURE TUMOR DISEASES.
UY25544A1 (en) NEFAZODONE DOSAGE FORM
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
DE69942921D1 (en) Osmotic dosage form with prolonged release of active ingredient
ES2185816T3 (en) FORMS OF PHARMACEUTICAL DOSAGE FOR THE ORAL ROUTE, WHICH INCLUDE AN INHIBITING AGENT OF THE PUMP OF PROTONS AND A PROCEDURAL AGENT.
ATE286387T1 (en) EXTENDED RELEASE PREPARATION CONTAINING CLARITHROMYCIN
DZ3473A1 (en) PHARMACEUTICAL FORMULATION WITH INDEPENDENT SUSTAINED RELEASE OF ION FORCE.
AR020205A1 (en) STERILIZING EFERVESCENT FORMULATION.
UY26503A1 (en) "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL"
ATE445393T1 (en) TABLET WITH COLORED CORE
BR0208865A (en) Applicator for application of beneficial agent on teeth and use of an applicator
ECSP003856A (en) DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL
AR030964A1 (en) A PHARMACEUTICAL FORMULATION WITH A MATRIX THAT FORM A HYDROPHILIC GEL, FORMULATION THAT INCLUDES ONE OR MORE ACTIVE SUBSTANCES, AND METHOD TO PREPARE SUCH FORMULATION THAT HAS A SUBSTANTIELY INDEPENDENT PROLONGED RELEASE OF THE IONIC FORCE
CO5550461A2 (en) TREATMENT OF PARASITARY DISEASE

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20121228